The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leuk Lymphoma. 2013 Feb; 54(2):252-4.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Cell Transformation, Neoplastic
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Prolymphocytic
Male
Middle Aged
Neoplasm Staging
Treatment Outcome
Vidarabine

authors with profiles

Richard A. Larson